Skip to Content
815

Alexion Pharmaceuticals

  • Revenues ($M)$2,604
  • Revenue Percent Change16.6%
  • Profits ($M)$144
  • Profits Percent Change-78%
  • Assets ($M)$13,133
  • Employees2,924
  • Market Value — as of March 31, 2016 ($M)$31,284
  • Previous Rank941
  • Morning Consult Brand Index-
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
David R. Brennan
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New Haven, CT
Websitehttp://www.alexion.com
Years on Fortune 500 List-
Employees2,924

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$2,60416.6%
Profits ($M)$144-78%
Assets ($M)$13,133-
Total Stockholder Equity ($M)$8,259-
Market Value — as of March 31, 2016 ($M)$31,284-

Profit Ratios

Profit as % of Revenues5.5%
Profits as % of Assets1.1%
Profits as % of Stockholder Equity1.7%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.67
EPS % Change (from 2014)-79.4%
EPS % Change (5 year annual rate)5.2%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2015)3.1%
Total Return to Investors (5 year, annualized)36.5%
Total Return to Investors (10 year, annualized)43.8%